Guo Yan, Yu Hui, Wang Jing, Sheng Quanhu, Zhao Shilin, Zhao Ying-Yong, Lehmann Brian D
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA.
Key Laboratory of Resource Biology and Biotechnology in Western China, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.
Genes (Basel). 2018 Jan 10;9(1):29. doi: 10.3390/genes9010029.
Triple-negative breast cancer (TNBC) is an operational term for breast cancers lacking targetable estrogen receptor expression and HER2 amplifications. TNBC is, therefore, inherently heterogeneous, and is associated with worse prognosis, greater rates of metastasis, and earlier onset. TNBC displays mutational and transcriptional diversity, and distinct mRNA transcriptional subtypes exhibiting unique biology. High-throughput sequencing has extended cancer research far beyond protein coding regions that include non-coding small RNAs, such as miRNA, isomiR, tRNA, snoRNAs, snRNA, yRNA, 7SL, and 7SK. In this study, we performed small RNA profiling of 26 TNBC cell lines, and compared the abundance of non-coding RNAs among the transcriptional subtypes of triple negative breast cancer. We also examined their co-expression pattern with corresponding mRNAs. This study provides a detailed description of small RNA expression in triple-negative breast cancer cell lines that can aid in the development of future biomarker and novel targeted therapies.
三阴性乳腺癌(TNBC)是指缺乏可靶向的雌激素受体表达且HER2无扩增的乳腺癌的一个操作性术语。因此,TNBC本质上具有异质性,并且与更差的预后、更高的转移率和更早的发病相关。TNBC表现出突变和转录多样性,以及具有独特生物学特性的不同mRNA转录亚型。高通量测序已将癌症研究扩展到远远超出包括非编码小RNA(如miRNA、isomiR、tRNA、snoRNA、snRNA、yRNA、7SL和7SK)在内的蛋白质编码区域。在本研究中,我们对26种TNBC细胞系进行了小RNA分析,并比较了三阴性乳腺癌转录亚型之间非编码RNA的丰度。我们还研究了它们与相应mRNA的共表达模式。本研究详细描述了三阴性乳腺癌细胞系中小RNA的表达情况,这有助于未来生物标志物的开发和新型靶向治疗。